Cargando…

Global prevalence and determinants of mortality among patients with COVID-19: A systematic review and meta-analysis

BACKGROUND: The challenge of COVID-19 is very high globally due to a lack of proven treatment and the complexity of its transmission. The prevalence of in-hospital mortality among patients with COVID-19 was very high which ranged from 1 to 52% of hospital admission. The prevalence of mortality among...

Descripción completa

Detalles Bibliográficos
Autores principales: Abate, Semagn Mekonnen, Checkol, Yigrem Ali, Mantefardo, Bahiru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931690/
https://www.ncbi.nlm.nih.gov/pubmed/33692899
http://dx.doi.org/10.1016/j.amsu.2021.102204
_version_ 1783660344147705856
author Abate, Semagn Mekonnen
Checkol, Yigrem Ali
Mantefardo, Bahiru
author_facet Abate, Semagn Mekonnen
Checkol, Yigrem Ali
Mantefardo, Bahiru
author_sort Abate, Semagn Mekonnen
collection PubMed
description BACKGROUND: The challenge of COVID-19 is very high globally due to a lack of proven treatment and the complexity of its transmission. The prevalence of in-hospital mortality among patients with COVID-19 was very high which ranged from 1 to 52% of hospital admission. The prevalence of mortality among intensive care patients with COVID-19 was very high which ranged from 6% to 86% of admitted patients. METHODS: A three-stage search strategy was conducted on PubMed/Medline; Science direct Cochrane Library. The Heterogeneity among the included studies was checked with forest plot, χ2 test, I2 test, and the p-values. Publication bias was checked with a funnel plot and the objective diagnostic test was conducted with Egger's correlation, Begg's regression tests. RESULT: The Meta-Analysis revealed that the pooled prevalence of in-hospital mortality in patients with coronavirus disease was 15% (95% CI: 13 to 17). Prevalence of in-hospital mortality in patients with COVID-19 was strongly related to different factors. Patients with Acute respiratory distress syndrome were eight times more likely to die as compared to those who didn't have, RR = 7.99(95% CI: 4.9 to 13). CONCLUSION: The review revealed that more than fifteen percent of patients admitted to the hospital with coronavirus died. This presages the health care stakeholders to manage morbidity and mortality among patients with coronavirus through the mobilization of adequate resources and skilled health care providers. REGISTRATION: This systematic review and meta-analysis was registered in research registry with UIN of reviewregistry1093.
format Online
Article
Text
id pubmed-7931690
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-79316902021-03-05 Global prevalence and determinants of mortality among patients with COVID-19: A systematic review and meta-analysis Abate, Semagn Mekonnen Checkol, Yigrem Ali Mantefardo, Bahiru Ann Med Surg (Lond) Systematic Review / Meta-analysis BACKGROUND: The challenge of COVID-19 is very high globally due to a lack of proven treatment and the complexity of its transmission. The prevalence of in-hospital mortality among patients with COVID-19 was very high which ranged from 1 to 52% of hospital admission. The prevalence of mortality among intensive care patients with COVID-19 was very high which ranged from 6% to 86% of admitted patients. METHODS: A three-stage search strategy was conducted on PubMed/Medline; Science direct Cochrane Library. The Heterogeneity among the included studies was checked with forest plot, χ2 test, I2 test, and the p-values. Publication bias was checked with a funnel plot and the objective diagnostic test was conducted with Egger's correlation, Begg's regression tests. RESULT: The Meta-Analysis revealed that the pooled prevalence of in-hospital mortality in patients with coronavirus disease was 15% (95% CI: 13 to 17). Prevalence of in-hospital mortality in patients with COVID-19 was strongly related to different factors. Patients with Acute respiratory distress syndrome were eight times more likely to die as compared to those who didn't have, RR = 7.99(95% CI: 4.9 to 13). CONCLUSION: The review revealed that more than fifteen percent of patients admitted to the hospital with coronavirus died. This presages the health care stakeholders to manage morbidity and mortality among patients with coronavirus through the mobilization of adequate resources and skilled health care providers. REGISTRATION: This systematic review and meta-analysis was registered in research registry with UIN of reviewregistry1093. Elsevier 2021-03-04 /pmc/articles/PMC7931690/ /pubmed/33692899 http://dx.doi.org/10.1016/j.amsu.2021.102204 Text en © 2021 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Systematic Review / Meta-analysis
Abate, Semagn Mekonnen
Checkol, Yigrem Ali
Mantefardo, Bahiru
Global prevalence and determinants of mortality among patients with COVID-19: A systematic review and meta-analysis
title Global prevalence and determinants of mortality among patients with COVID-19: A systematic review and meta-analysis
title_full Global prevalence and determinants of mortality among patients with COVID-19: A systematic review and meta-analysis
title_fullStr Global prevalence and determinants of mortality among patients with COVID-19: A systematic review and meta-analysis
title_full_unstemmed Global prevalence and determinants of mortality among patients with COVID-19: A systematic review and meta-analysis
title_short Global prevalence and determinants of mortality among patients with COVID-19: A systematic review and meta-analysis
title_sort global prevalence and determinants of mortality among patients with covid-19: a systematic review and meta-analysis
topic Systematic Review / Meta-analysis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931690/
https://www.ncbi.nlm.nih.gov/pubmed/33692899
http://dx.doi.org/10.1016/j.amsu.2021.102204
work_keys_str_mv AT abatesemagnmekonnen globalprevalenceanddeterminantsofmortalityamongpatientswithcovid19asystematicreviewandmetaanalysis
AT checkolyigremali globalprevalenceanddeterminantsofmortalityamongpatientswithcovid19asystematicreviewandmetaanalysis
AT mantefardobahiru globalprevalenceanddeterminantsofmortalityamongpatientswithcovid19asystematicreviewandmetaanalysis